B15 Acute hepatitis A

Name of the Condition

• Acute hepatitis A

Summary

Acute hepatitis A is a viral infection that causes inflammation of the liver. It is typically a self-limiting condition, though symptoms can range from mild to severe. The infection is characterized by acute onset of liver dysfunction, often with systemic symptoms, and generally resolves without long-term liver damage in most individuals.

Causes

The condition is caused by the hepatitis A virus (HAV), a non-enveloped RNA virus belonging to the Hepatovirus genus. Transmission occurs primarily through the fecal-oral route, often via ingestion of contaminated food or water, or close contact with an infected individual. The virus replicates in the liver, leading to hepatocellular injury and the associated clinical manifestations.

Risk Factors

• Consumption of contaminated food or water, particularly in areas with poor sanitation.
• Close contact with an infected person, including household or sexual contact.
• Travel to regions with high endemicity of hepatitis A.
• Men who have sex with men (MSM) or individuals engaging in high-risk sexual practices.
• Use of injection drugs or sharing needles.
• Occupational exposure, such as in healthcare or childcare settings.

Symptoms

• Fatigue, malaise, and fever.
• Jaundice (yellowing of the skin and eyes).
• Dark urine and pale stools.
• Abdominal pain, especially in the right upper quadrant.
• Nausea, vomiting, and loss of appetite.
• Joint pain or rash in some cases.

Diagnosis

Diagnosis is confirmed through laboratory testing, typically involving detection of hepatitis A virus antibodies (IgM anti-HAV) in the blood, which indicates acute infection. Liver function tests (LFTs) may show elevated transaminases (ALT, AST) and bilirubin levels. In some cases, viral RNA detection via PCR may be used for confirmation, especially in early infection or immunocompromised individuals. Clinical evaluation, including history of exposure or travel, supports the diagnosis.

Treatment Options

Treatment for acute hepatitis A is primarily supportive, as the infection is self-limiting. Rest, adequate hydration, and nutritional support are recommended. Symptomatic relief for nausea, pain, or fever may be provided as needed. Hospitalization is rare but may be required for severe cases, particularly in older adults or those with pre-existing liver disease. No specific antiviral therapy is approved for hepatitis A.

Prognosis and Follow-Up

Most individuals with acute hepatitis A recover fully within a few weeks to months, with no long-term liver damage. Prognosis is generally excellent, though older adults or those with underlying liver conditions may experience more severe disease. Follow-up typically includes monitoring of liver function tests until they normalize. Immunity after infection is lifelong, and recurrence is not observed.

Complications

While rare, complications can include fulminant hepatitis (acute liver failure), which may require liver transplantation. Other potential complications include cholestatic hepatitis (prolonged jaundice) or relapsing hepatitis, where symptoms reappear after initial improvement. In immunocompromised individuals, prolonged viral shedding or chronic infection is not typical but may occur.

Lifestyle & Prevention

Prevention focuses on hygiene and vaccination. Good handwashing practices, especially after using the restroom or before eating, reduce transmission risk. The hepatitis A vaccine is highly effective and recommended for individuals at high risk, including travelers to endemic areas, MSM, and those with liver disease. Avoiding contaminated food and water, particularly in regions with poor sanitation, is also critical.

When to Seek Professional Help

Seek medical attention if symptoms such as jaundice, severe abdominal pain, or persistent vomiting occur. Individuals with pre-existing liver disease or weakened immune systems should consult a healthcare provider promptly if exposed to hepatitis A. Emergency care is warranted for signs of acute liver failure, such as confusion, bleeding, or severe fatigue.

Tips for Medical Coders

When coding for acute hepatitis A (B15), ensure documentation supports the acute nature of the infection, as opposed to chronic hepatitis. Verify that the diagnosis is confirmed by laboratory testing (e.g., IgM anti-HAV) and that no other hepatitis viruses are present, unless specified. Document any complications or risk factors (e.g., travel history, exposure) to support the code assignment. Avoid coding for asymptomatic carriers or resolved infections, as these do not align with the acute diagnosis.